The INIMAC laboratory focuses on the processes leading to the activation of innate immune cells, in particular macrophages and natural killer (NK) cells. Innate immune cells are critical initiators and contributors to a wide spectrum of diseases. Innate immune activation relies on indirect or direct cell contact, involving interferons and cytokines or receptor-ligand interactions, respectively. In the lab we strive to understand the complex interplay of molecules and cells on the activation of macrophages and NK cells in response to infections as well as in granulomatous diseases and histiocytoses. Another line of research is aimed at dissecting the role and contribution of macrophages and NK cells to the tumor microenvironment and tumor progression.
We are studying innate immune cells both on a functional systems biology and functional cellular level. We aim at reprogramming their epigenomic potential to elicit improved responses towards pathogens and cancer. We build on a lineup of recently in house developed and established next generation sequencing (NGS) technologies, which can serve through systems level multi-omics integration to identify critical players at the molecular and cellular level. This requires a tight integration of wet-lab and computational scientists to apply the right strategies to the right kind of biological problem and question.